"What human health innovation policy does not need is a brilliant but scientifically uninformed Supreme Court advocate, Paul Clement, guessing that genus claims 'retard the science.'How would he know?" - Judge Paul Michel
The U.S. Supreme Court heard three separate arguments today in Amgen v. Sanofi, a case that even Sanofi's counsel agreed could effectively wipe out patents involving genus claims if the Court sides with Sanofi, or-as counsel for Sanofi and the Solicitor General's Office suggested the Court could do-if it were to dismiss the case as improvidently granted (DIG).
The U.S. Supreme Court heard three separate arguments today in Amgen v. Sanofi, a case that even Sanofi's counsel agreed could effectively wipe out patents involving genus claims if the Court sides with Sanofi, or-as counsel for Sanofi and the Solicitor General's Office suggested the Court could do-if it were to dismiss the case as improvidently granted (DIG).
[
add
]
[
|
|
...
]